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Abstract
Lymphatic filariasis can be associated with development of serious pathology in the form of lymphedema, hydrocele, and
elephantiasis in a subset of infected patients. Dysregulated host inflammatory responses leading to systemic immune
activation are thought to play a central role in filarial disease pathogenesis. We measured the plasma levels of microbial
translocation markers, acute phase proteins, and inflammatory cytokines in individuals with chronic filarial pathology with
(CP Ag+) or without (CP Ag2) active infection; with clinically asymptomatic infections (INF); and in those without infection
(endemic normal [EN]). Comparisons between the two actively infected groups (CP Ag+ compared to INF) and those
without active infection (CP Ag2 compared to EN) were used preliminarily to identify markers of pathogenesis. Thereafter,
we tested for group effects among all the four groups using linear models on the log transformed responses of the markers.
Our data suggest that circulating levels of microbial translocation products (lipopolysaccharide and LPS-binding protein),
acute phase proteins (haptoglobin and serum amyloid protein-A), and inflammatory cytokines (IL-1b, IL-12, and TNF-a) are
associated with pathogenesis of disease in lymphatic filarial infection and implicate an important role for circulating
microbial products and acute phase proteins.
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Introduction
Although two-thirds of the 120 million people infected with
Wuchereria bancrofti—the major causative agent of human lymphatic
filariasis—have subclinical infections, ,40 million have lymph-
edema and/or other pathologic manifestations including hydro-
celes (and other forms of urogenital disease), episodic adenolym-
phangitis, tropical pulmonary eosinophilia, lymphedema, and (in
its most severe form) elephantiasis [1]. It is assumed that repeated
episodes of acute inflammation can lead to development of serious
disfigurement in the face of compromised lymphatics [2], although
many other factors that contribute to the pathology associated
with lymphatic filariasis are largely unknown. Typically in
Wuchereria or Brugia infections, disease manifests years after
exposure, while clinically asymptomatic infection is not only more
common but can occur at a relatively young age [3,4].
Lymphatic filarial disease is felt to be a reflectionof both localized
and systemic immunologic and inflammatory responses mediated
by pro-inflammatory cytokines and chemokines [5,6]. Although
some of the pathological changes can likely be initiated by
Wolbachia- or parasite-encoded endotoxin-like substances and/or
secondary bacterial or fungal infections [1,7], chronic parasite-
induced immune activation is a salient feature of filarial disease.
Indeed, increased frequencies of activated T cells [8], increased
parasite antigen-driven Th1 and Th17 cytokine production [6],
increased expression of Toll-like and NOD-like receptors [6], and
enhanced TLR signaling through TLR ligand stimulation [5] have
all been described when comparisons are made between patients
with subclinical infection and those with filarial lymphedema and/
or elephantiasis. Moreover, innate immune responses also play a
prominent role in development of pathology, as evidenced by the
occurrence of lymphatic damage in animal models of filarial
infection lacking an adaptive immune system [9].
Persistent immune activation is associated with elevations of
circulating microbial products, acute phase proteins, and the so-
called microbial translocation molecules [10]. Translocation of
microbial products from the lumen of the intestine into the
periphery is thought to contribute to induction of inflammation by
stimulating immune effector cells directly through their pattern
recognition receptors [11]; however, intra- and peri-lymphatic
damage—an underlying feature of filarial disease [12]—might also
contribute to the presence of microbial translocation products in
the bloodstream. In addition, chronic immune activation that
often accompanies infectious processes [13] is associated with
development of an acute phase response and the presence of
markers of inflammation in plasma. Moreover, increased serum
levels of proinflammatory cytokines and chemokines are com-
monly associated with progressive immune activation.
PLoS Pathogens | www.plospathogens.org 1 June 2012 | Volume 8 | Issue 6 | e1002749In this study, we have delineated the role of many of the known
markers of inflammation and lymphatic damage that reflect the
dysregulated (or unchecked) responses related to development of
disease with the lymphatic-dwelling filariae (Wuchereria bancrofti and
Brugia malayi). Our data suggest that circulating (systemic)
microbial products, acute phase proteins, and pro-inflammatory
cytokines reflect the localized (and ongoing) chronic immune
activation that underlies the pathogenesis of disease in lymphatic
filariasis.
Materials and Methods
Study population
We studied a group of 91 individuals with filarial lymphedema
without active filarial infection (hereafter CP Ag2), 28 individuals
with filarial lymphedema with active filarial infection (hereafter CP
Ag+), 98 asymptomatic or subclinical, infected individuals
(hereafter INF), and 82 uninfected, endemic normal individuals
(hereafter EN) in an area endemic for lymphatic filariasis in Tamil
Nadu, South India (table 1). Diagnosis of active filarial infection
was performed by measuring circulating filarial antigen levels by
both the ICT filarial antigen test (Binax, Portland, ME, USA) and
the TropBio Og4C3 enzyme-linked immunosorbent assay
(ELISA) (Trop Bio Pty. Ltd, Townsville, Queensland, Australia).
All the CP Ag2 individuals had undergone treatment with
repeated doses of diethylcarbamazine (DEC). None of the CP Ag+
individuals had received any DEC treatment but were adminis-
tered DEC following the blood draw. All of the CP individuals had
early stage lymphedema (Grades 1 and 2) only and individuals
with concurrent overt and active bacterial infection were excluded
from the study. All individuals were examined as part of a clinical
protocol approved by Institutional Review Boards of both the
National Institute of Allergy and Infectious Diseases and the
Tuberculosis Research Center (NCT00375583 and
NCT00001230), and informed written consent was obtained from
all participants.
Microbial translocation assays
To inactivate plasma proteins, plasma samples were heated to
75uC for 5 min. Lipopolysaccharide (LPS) levels were measured
using a limulus amebocyte lysate assay (Cell Sciences Hycult
Biotech, Canton, MA, USA) according to the manufacturer’s
protocol. Commercially available ELISA kits were used to
measure plasma levels of LPS- binding protein (LBP), endotoxin
core antibodies IgG (EndoCAb) (Cell Sciences Hycult Biotech),
and soluble CD14 (sCD14) (R&D Systems, Minneapolis, MN,
USA).
Acute phase proteins
Plasma levels of C-reactive protein (CRP), haptoglobin, serum
amyloid protein - A (SAA), and a-2 macroglobulin (a-2M) were
measured using the Bioplex (Bio-Rad, Hercules, CA, USA)
multiplex ELISA system according to the manufacturer’s instruc-
tions.
Cytokines
Plasma levels of cytokines, IL-1b, IL-6, IL-12, and TNF-a (Bio-
Rad) were measured using the Bioplex multiplex ELISA system.
Statistical analysis
Data analyses were performed using GraphPad PRISM
(GraphPad Software, Inc., San Diego, CA, USA). Geometric
means (GM) were used for measurements of central tendency.
Preliminary statistical analysis was done using the non-parametric
Mann-Whitney test. We then tested for group effects using linear
models on the log transformed data. We used robust standard
error with a recommended bias adjustment so that we need not
assume that the error variance was the same for each group. We
parameterized the 4 group effects using parameters for CP,
infection, and CP by infection interaction. Since we tested these 3
parameters on 12 markers, we adjusted the p-values for multiple
comparisons using Holm’s adjustment. P-values in Table 2 are
Holm’s adjusted. We then built specific models using only the
significant (when Holm’s adjusted p-value,0.05) effects, and we
present those effects and (unadjusted) 95% confidence intervals as
fold-change (Table 3). We repeated the models after adding an
effect for age (either as a continuous or a categorical variable).
Linear models were done in R 2.14.0 using the sandwich R
package. Correlations were calculated by the Spearman rank
correlation test.
The heat map was constructed in JMP v8.0 (SAS, Carey, NC)
and is based on relative expression for a given analyte as a function
of the geometric mean value found in the endemic normal
population.
Results
CP Ag+ exhibit elevated levels of LPS but lower levels of
LBP compared with INF
To determine the association of microbial translocation and
related markers with filarial lymphedema, we measured the
plasma levels of LPS, LPB, EndoCAb, and sCD14 in CP Ag+,
INF, CP Ag2, and EN. As shown in figure 1, CP Ag+ had
significantly higher levels of LPS (GM of 4.24 EU/ml in CP Ag+
vs. 0.10 in INF; P,0.0001 by Mann-Whitney) but not sCD14 or
EndoCAb in comparison to INF. Conversely, CP Ag+ had
significantly lower levels of LBP (GM of 306.2 ng/ml in CP Ag+
vs. 21658 in INF; P,0.0001) in comparison to INF. However, no
significant differences were observed in the levels of all four
circulating microbial or related products between CP Ag2 and
Author Summary
Lymphatic filariasis afflicts over 120 million people world-
wide. While the infection is mostly clinically asymptomatic,
approximately 40 million people suffer from overt, morbid
clinical pathology, characterized by swelling of the scrotal
area and lower limbs (hydrocele and lymphedema). Host
immunologic factors that influence the pathogenesis of
disease in these individuals are not completely under-
stood. Circulating microbial products such as LPS and
markers associated with microbial translocation have been
shown to play an important role in disease pathogenesis
of certain infections like HIV. Similarly, proteins associated
with the acute phase response and related cytokines also
play an important role in pathogenesis. We have attempt-
ed to elucidate the role of the above mentioned factors in
disease pathogenesis by comparing the plasma levels of
the various markers in four groups of individuals: chronic
pathology individuals with or without active filarial
infection, asymptomatic, filarial infected individuals and
uninfected, endemic normal individuals. We show that
circulating levels of LPS, acute phase proteins and certain
cytokines are significantly elevated in filarial disease with
active infection but not in the other groups indicating that
filarial infection induced increased production of these
factors correlated with the development of filarial lym-
phatic pathology.
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between LPS and LBP levels in the CP Ag+ group (r2=0.862;
P,0.0001). Thus, filarial lymphedema with active infection is
characterized by elevated levels of circulating LPS.
CP Ag+ exhibit elevated levels of CRP, haptoglobin, SAA,
and a-2m compared with INF
To determine the association of acute phase proteins with
filarial disease, we measured the plasma levels of CRP, haptoglo-
bin, SAA, and a-2m in the four groups. As shown in figure 2, CP
Ag+ had significantly higher levels of CRP (GM of 30.9 pg/ml in
CP Ag+ vs. 4.11 in INF; P,0.0001), haptoglobin (GM of
555.9 pg/ml in CP Ag+ vs. 140.1 in INF; P,0.0001), SAA (GM
of 196.7 pg/ml in CP Ag+ vs. 96.9 in INF; P=0.0037), and a-2m
(GM of 4383 pg/ml in CP Ag+ vs. 1923 pg/m in INF; P=0.0003)
in comparison to INF. Similarly, among those without evidence of
active filarial infection (Ag2), those with CP had significantly
higher levels of CRP in comparison to EN (GM of 14.5 pg/ml in
CP Ag2 vs.1.9 in EN; P,0.0001), indicating that elevated CRP
levels might be more reflective of the secondary events associated
with pathology than with active infection. Thus, filarial lymph-
edema with active infection is characterized by elevated levels of
several acute phase proteins.
CP Ag+ exhibit elevated levels of IL-1b, IL-12, and TNF-a
compared with INF
To determine the association of inflammatory cytokines with
filarial lymphedema, we measured the plasma levels of IL-1b, IL-
6, IL-12, and TNF-a in the four groups of subjects. As shown in
figure 3, compared with INF, those with CP Ag+ had significantly
higher levels of IL-1b (GM of 410.9 pg/ml in CP Ag+ vs. 210.3 in
INF; P=0.0305), IL-12 (GM of 989.1 pg/ml in CP Ag+ vs. 61.2
in INF; P,0.0001), and TNF-a (GM of 2455 pg/ml in CP Ag+ vs.
727.2 in INF; P,0.0001) but not IL-6. However, no significant
differences were observed in the levels of all four cytokines
between those without active infection (EN and CP Ag2)
irrespective of clinical status. Thus, filarial lymphedema with
active infection is characterized by elevated plasma levels of
inflammatory cytokines.
Linear models on log transformed markers for all the four
groups
We tested for three effects (CP effect, infection effect, and CP-
by-infection interaction effect) on each of 12 markers using linear
models on the log transformed responses. A significant (CP-by-
infection) interaction effect meant that the geometric mean (GM)
for the marker in the CP Ag+ group is significantly different from
GM expected from the combined effects of CP and infection. As
shown in Table 2, we observed significant effects in the models for
LPS, LBP, CRP, Haptoglobin, SAA, IL-1b, IL-6, IL-12 and TNF-
a. We then examined the details of the significant markers by
rebuilding the linear model using only the significant (by adjusted
p-value) effects. For LPS, Haptoglobin, IL-1b, and IL-12, we
observed that the CP Ag+ group had significantly higher responses
than the other 3 groups, while for LBP we observed that the CP
Ag+ group has significantly lower responses than the other groups
(see Table 3). For the 4 other markers with significant effects
(CRP, SAA, IL-6, and TNF-a), we observed that CRP was
Table 1. Characteristics of the study population.
Endemic Normal Infected Chronic Pathology Chronic Pathology
(EN) (n=82) (INF) (n=98) (CP Ag+)( n=28) (CPAg2)( n=91)
Age 26 (20–50) 36 (15–73) 44 (18–69) 38 (17–70)
Sex M/F 44/38 52/46 19/9 47/44
CFA* (IU) ,32 3126 (136–32000) 1606 (464–8996) ,32
Pathology Stages 1/2 Nil Nil 12/16 42/49
*CFA values are determined by the Og4C3 ELISA and 32 IU was the threshold of detection in the assay.
doi:10.1371/journal.ppat.1002749.t001
Table 2. Holm’s adjusted p-values from Linear Models, No
Age Effect, n=sample size.
CP Effect Infection Effect Interaction Effect n
LPS 0.6582 1.0000 ,.0001 241
LBP 1.0000 1.0000 ,.0001 232
EndoCAb 1.0000 1.0000 1.0000 249
sCD14 1.0000 1.0000 1.0000 289
CRP ,.0001 0.5797 1.0000 254
Haptoglobin 1.0000 1.0000 0.0001 210
SAA 1.0000 0.0357 0.8703 254
a-2-Macroglobulin 1.0000 0.6683 0.2362 251
IL-1b 1.0000 0.8534 0.0279 279
IL-6 0.0418 ,.0001 0.5155 232
IL-12 1.0000 1.0000 ,.0001 289
TNF-a 1.0000 0.0088 0.1485 278
doi:10.1371/journal.ppat.1002749.t002
Table 3. Fold-change for geometric mean of CP Ag+ group
compared to others, with (unadjusted) 95% confidence
intervals (CI).
Fold change Lower CI Upper CI
LPS 54.27 19.11 154.14
LBP 0.012 0.004 0.043
Haptoglobin 3.14 1.96 5.01
IL-1b 3.15 1.60 6.19
IL-12 14.89 9.10 24.38
doi:10.1371/journal.ppat.1002749.t003
Inflammatory Markers in Filariasis
PLoS Pathogens | www.plospathogens.org 3 June 2012 | Volume 8 | Issue 6 | e1002749significantly associated with chronic pathology (both CP Ag+ and
CP Ag2); SAA and TNF- a were significantly associated with
infection status (both CP Ag+ and INF); and IL-6 was associated
withboth pathology and the infection status (data not shown).Thus,
by using robust statistical calculations, we have confirmed the
association of LPS, acute phase proteins and inflammatory
cytokines with filarial lymphedema with active infection. A more
detailed examination of the associations is presented in the Text S1.
Relationships between LPS/LBP levels and inflammatory
cytokines in infected individuals
The relationships between the levels of LPS and/or LBP levels
and plasma cytokines were next assessed (figure 4). As shown in
figure 4A, levels of LPS exhibited a highly significant positive
correlation with the plasma levels of IL-1b (r=0.4942; P,0.001),
IL-12 (r=0.4802; P,0.0001), and TNF-a (r=0.4494; P,0.0001)
in all actively infected individuals. Conversely, LBP levels were
significantly negatively correlated with the plasma levels of IL-12
(r=20.3255; P=0.0005) (figure 4B). Thus, the process by which
microbial translocation occurs appears to be significantly associ-
ated with the pro-inflammatory cytokine levels in filarial infection.
We also compiled the comparative analysis of all the 12
parameters in the 4 groups of individuals as a heat map, depicting
the log transformed data on a scale relative to EN. As shown in
figure 5, CP Ag+ individuals exhibit a distinct biomarker signature
characterized by elevated levels of LPS, acute phase proteins, and
certain inflammatory cytokines compared with the other 3 groups
(EN, INF, and CP Ag2), again reiterating the important
association of these factors with pathogenesis of filarial pathology.
Discussion
Studies in experimental animal models suggest that intestinal
injury and systemic endotoxemia are two major factors leading to
morbidity in helminth infections [14,15]. Disruption of the
integrity of the intestinal epithelium and translocation of microbial
products into the circulation is thought to occur in intestinal
helminth infections [16]. Thus, infection with intestinal helminths
is characterized by enhanced leakiness of the intestinal epithelium,
mediated by activated mast cells, which can lead to the movement
of bacterial LPS into the portal circulation [17,18]. Even in non-
intestinal helminth infections, such as schistosomes that reside in
the mesenteric veins, damage caused by worm eggs traversing the
gastrointestinal epithelium can result in systemic translocation of
bacteria [14,19]; however, the role of microbial translocation in
the pathogenesis of disease in systemic helminth infections is not
clear.
Figure 1. Filarial lymphedema is associated with elevated levels of LPS. Plasma levels of LPS, LBP, EndoCAb and sCD14 from asymptomatic
infected [INF] individuals; filarial lymphedema individuals with active infection [CP Ag+]; filarial lymphedema individuals without active infection [CP
Ag2] and endemic normal [EN] individuals were measured by ELISA and immunoassays. Data are shown as scatter plots with the bar representing
the geometric mean.
doi:10.1371/journal.ppat.1002749.g001
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of lymphatics leading to severe (and often) irreversible lymphede-
ma and elephantiasis. It has been shown that residence of adult
parasites in the lymphatics leads to a cascade of events that
ultimately results in tissue scarring and fibrosis [20]. Studies
addressing the mechanisms underlying parasite-induced lymphatic
dilatation suggest that parasite-mediated lymphatic dilatation and
lymphangiogenesis might be important features in the develop-
ment of pathology [7,12]. In addition, the more severe forms of
lymphedema are often associated with secondary bacterial and/or
fungal infections leading to dermatolymphangioadenitis, which
also contribute to the pathogenesis of disease [2]. Finally, filarial
lymphedema has been shown to be associated with increased
bacterial loads in the lymphatics [21,22,23,24]; these damaged
lymphatics could then serve as a potential nidus for bacterial
translocation through the lymphatic endothelium. Thus, the
predominant feature of lymphatic filarial disease is the establish-
ment of a systemic inflammatory milieu due to both parasite-
derived and host-induced inflammation.
We examined four important circulating microbial or related
products in our study. LPS (a key indicator of microbial
translocation) was found to be significantly elevated in CP Ag+
compared with INF but not in CP Ag2 compared with EN. In
addition, LPS levels were also found to be significantly elevated in
the CP Ag+ compared to all the other 3 groups combined or
individually. Strikingly, we observed the exactly opposite profile
with LBP, the LPS binding protein commonly produced by
gastrointestinal and hepatic epithelial cells in response to LPS
stimulation [25]. LBP is also known to bind and transfer LPS to
high-density lipoproteins to decrease the bioactivity of LPS [25]
and therefore, the lower levels of LBP in CP Ag+ individuals might
reflect an inability to clear LPS in circulation. Although we
examined the levels of sCD14, which binds LPS and is produced
by monocytes/macrophages [25], and the naturally occurring IgG
antibody to the LPS core oligosaccharide (EndoCAb) [26] in all
groups of subjects, we found no differences in these particular
molecules. Our study therefore suggests that circulating LPS and
LBP (but not sCD14 or EndoCAb) are potentially associated either
with the development of pathology or function as markers for
pathogenesis. While elevated levels of LPS in CP Ag+ compared
with INF could potentially be attributed to presence of secondary
bacterial infection, the elevated immune activation observed in
chronic pathology patients with active infection suggests that the
interaction between filarial infection and pathology is a major
contributor to microbial translocation, fueling systemic immune
activation. Interestingly, our findings are similar to findings
Figure 2. Filarial lymphedema is associated with elevated levels of acute phase proteins. Plasma levels of CRP, Haptoglobin, SAA and a-2
macroglobulin from asymptomatic infected [INF] individuals; filarial lymphedema individuals with active infection [CP Ag+]; filarial lymphedema
individuals without active infection [CP Ag2] and endemic normal [EN] individuals were measured by ELISA. Data are shown as scatter plots with the
bar representing the geometric mean.
doi:10.1371/journal.ppat.1002749.g002
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immune activation, including HIV [27,28], hepatitis B and C [29],
and schistosomiasis [19,30].
Acute phase proteins derive primarily from the liver, and
plasma concentrations are felt to be a reflection of the response to
pro-inflammatory cytokines [31]. Measurement of acute phase
proteins is of clinical importance in determining the presence and
extent of inflammatory tissue damage as well as in providing
diagnostic and prognostic information [32,33]. Moreover, circu-
lating microbial products are well known inducers of acute phase
proteins, with SAA and haptoglobin known to be markedly
elevated following challenge with LPS [34]. Elevated levels of CRP
have been reported in lymphatic filarial disease [35], but other
acute phase proteins have not been examined. In the present
study, we confirmed that CRP levels are indeed elevated in
actively infected patients with chronic lymphedema compared
with the asymptomatic group, but we also found that haptoglobin,
SAA, and a-2m are also elevated. Upon, further analysis, only
haptoglobin was observed to be significantly associated with
filarial-infection with pathology, while SAA was significantly
associated with filarial infection per se (both CP Ag+ and INF).
Interestingly, CRP levels were significantly elevated even in those
patients with chronic lymphedema without active infection,
indicating that CRP is probably a nonspecific marker of
inflammation in filarial disease, whereas haptoglobin might serve
as a more accurate biomarker of filarial infection-driven pathol-
ogy.
Although persistent and progressive inflammation is postulated
to be a hallmark of lymphatic filarial disease, very few studies have
actually examined the levels of inflammatory cytokines or
chemokines in the circulation of infected or diseased individuals.
Previous reports have suggested that IL-6 and IL-8 are morbidity
markers in acute and chronic disease [36], while IL-6 and TNF-a
are involved in the pathogenesis of adverse reactions following
treatment [37]. Our examination of cytokine expression levels in
the four groups of individuals reveals that IL-1b and IL-12 are
significantly associated with overt pathology in actively infected
individuals. Conversely, TNF-a was associated significantly with
groups having active infection (CP Ag+ and INF) indicating a
possible association with filarial infection rather than pathology
alone. Because inflammatory cytokines are intricately linked to
induction of both circulating microbial products and acute phase
proteins, we also examined their interrelationship in the CP Ag+
population. Detection of microbial invasion by cells of the innate
immune system usually results in increased production of pro-
inflammatory cytokines such as IL-1b, IL-6, IL-12, and TNF-a
Figure 3. Filarial lymphedema is associated with elevated levels of inflammatory cytokines. Plasma levels of IL-1b, IL-6, IL-12 and TNF-a
from asymptomatic infected [INF] individuals; filarial lymphedema individuals with active infection [CP Ag+]; filarial lymphedema individuals without
active infection [CP Ag2] and endemic normal [EN] individuals were measured by ELISA. Data are shown as scatter plots with the bar representing
the geometric mean.
doi:10.1371/journal.ppat.1002749.g003
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levels of microbial translocation markers such as LPS and the
inflammatory cytokines [27,28]. In agreement with such studies,
our examination of filaria-infected individuals also reveals a
significantly positive association between LPS and pro-inflamma-
tory cytokines in filaria-infected-individuals. Our study clearly
implicates an association for LPS, the acute phase proteins, and
several of the pro-inflammatory cytokines with filaria-induced
lymphatic pathology.
Investigations into filarial disease pathogenesis have implicated
host pathways in disease progression. In particular, dysregulated
inflammatory responses and lymphatic dysfunction are thought to
be central processes in severe filarial pathology [7,12]. Our study
reveals novel insights into the pathogenesis of lymphatic filarial
dysfunction, despite some minor limitations. Since DEC had been
administered only to the CP Ag2 group and the presence of other
parasitic infections not examined, the effect of treatment with
DEC as well as the influence of other parasitic infections could not
be ascertained in this study.
Another minor limitation of the study was that plasma levels of
inflammatory markers—such as circulating microbial products,
acute phase proteins, and cytokines—are relatively nonspecific
and may be influenced by short half-life, nonspecific induction,
and plasma levels not reflecting biologic activity. Notwithstanding
these limitations, plasma levels of some of these same biomarkers
have yielded important insights in the diagnosis and/or prognosis
of various infectious diseases and cancers [10,38,39].
Our study clearly identifies a signature set of biomarkers that
serves to indicate filarial infection-driven morbidity associated with
a persistent and progressive inflammatory milieu. While requiring
validation in future studies, these results point to potential
prognostic indicators of severe filarial disease.
Figure 4. Correlation between circulating microbial products and inflammatory cytokines in filarial infected individuals. (A) Plasma
levels of LPS were correlated with the levels of IL-1b, IL-6, IL-12 and TNF-a from individuals with active infection [CP Ag+ and INF (n=108–112)]. (B)
Plasma levels of LBP were correlated with the levels of IL-1b, IL-6, IL-12 and TNF-a from individuals with active infection [CP Ag+ and INF (n=108–
112)]. P and r values were calculated using the Spearman Rank correlation test. Data are shown as scatter plots with the circles representing INF and
the triangles representing CP Ag+ individuals.
doi:10.1371/journal.ppat.1002749.g004
Figure 5. Heatmap depicting circulating microbial products, acute phase proteins and inflammatory cytokines in CP Ag+
individuals compared to EN, INF and CP Ag2 individuals. Data (and scale) are log10 geometric mean fold change from EN for each of the
analytes measured for each of the groups.
doi:10.1371/journal.ppat.1002749.g005
Inflammatory Markers in Filariasis
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Text S1 Linear models on log transformed data on all the
markers in all four groups (CP Ag+, INF, CP Ag2 and EN).
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